1. Home
  2. BPT vs MEIP Comparison

BPT vs MEIP Comparison

Compare BPT & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPT
  • MEIP
  • Stock Information
  • Founded
  • BPT 1989
  • MEIP 2000
  • Country
  • BPT United States
  • MEIP United States
  • Employees
  • BPT N/A
  • MEIP N/A
  • Industry
  • BPT Integrated oil Companies
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • BPT Energy
  • MEIP Health Care
  • Exchange
  • BPT Nasdaq
  • MEIP Nasdaq
  • Market Cap
  • BPT 11.7M
  • MEIP 13.3M
  • IPO Year
  • BPT N/A
  • MEIP 2003
  • Fundamental
  • Price
  • BPT $0.51
  • MEIP $2.53
  • Analyst Decision
  • BPT
  • MEIP Hold
  • Analyst Count
  • BPT 0
  • MEIP 1
  • Target Price
  • BPT N/A
  • MEIP N/A
  • AVG Volume (30 Days)
  • BPT 439.4K
  • MEIP 21.5K
  • Earning Date
  • BPT 08-08-2025
  • MEIP 05-13-2025
  • Dividend Yield
  • BPT N/A
  • MEIP N/A
  • EPS Growth
  • BPT N/A
  • MEIP N/A
  • EPS
  • BPT N/A
  • MEIP N/A
  • Revenue
  • BPT $211,000.00
  • MEIP N/A
  • Revenue This Year
  • BPT N/A
  • MEIP N/A
  • Revenue Next Year
  • BPT N/A
  • MEIP N/A
  • P/E Ratio
  • BPT N/A
  • MEIP N/A
  • Revenue Growth
  • BPT N/A
  • MEIP 33.76
  • 52 Week Low
  • BPT $0.40
  • MEIP $1.46
  • 52 Week High
  • BPT $2.57
  • MEIP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • BPT 39.52
  • MEIP 78.43
  • Support Level
  • BPT $0.49
  • MEIP $2.21
  • Resistance Level
  • BPT $0.55
  • MEIP $2.95
  • Average True Range (ATR)
  • BPT 0.07
  • MEIP 0.15
  • MACD
  • BPT -0.02
  • MEIP 0.05
  • Stochastic Oscillator
  • BPT 6.67
  • MEIP 81.48

About BPT BP Prudhoe Bay Royalty Trust

BP Prudhoe Bay Royalty Trust is a grantor trust operating in the US. The property of the Trust consists of an overriding royalty interest. The Royalty Interest entitles the Trust to receive the royalty from the production of crude oil and condensate from the working interest of BP Exploration (Alaska) Inc. in the Prudhoe Bay oil field located on the North Slope of Alaska.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: